ALMDT — Median Technologies SA Share News
0.000.00%
Last trade - 00:00- €160.70m
- €161.24m
- €23.36m
Brief: Median Technologies FY Revenue Up At 23.8 Million Euros
Brief: Median Technologies End-Sept Revenues Up At Eur 18.7 Mln
Brief: Median Technologies Q2 Revenue Up At EUR 7.0 Mln
Brief: Median Technologies: Moving Forward With FDA Interactions For Ibiopsy® Lung Cancer Screening CADe
Brief: Median Technologies FY Revenue Up At EUR 20.5 Million
Brief: Median Technologies Completes Design Of Ibiopsy® Lung Cancer Screening Software
Brief: Median Technologies SA - Aims To Obtain Full Device Approval & Market Authorization By 2023 End For Ibiopsy® Lung Cancer Screening Cade/Cadx Software
Brief: Median Technologies Q4 Revenue Up At EUR 5.1 Mln
Brief: Median Technologies Announces Lung Nodule Detection Performance For Ibiopsy® Lung Cancer Screening
Brief: Median Technologies Updates On iBiopsy's Performance
Brief: Median Technologies Q3 Revenue Rises To 5.3 Million Euros
Brief: Median Technologies Says Confirmed As Vendor By Undisclosed Pharmaceutical Company
Brief: Median Technologies Updates On Ibiopsy Lung Cancer Screening CADX1
Brief: Median Technologies Appoints Jean-Christophe Montigny As CFO
Brief: Median Technologies Appoints Jean-Christophe Montigny As CFO
Brief: Median Technologies FY Net Loss Widens To EUR 12.8 Mln
Fly Leasing: J.P.Morgan double-downgrades to 'underweight' after Carlyle's buy offer
Brief: Median Technologies Updates On Capital Increase Via Private Placement Of 28.1 Million Euros
Brief: Median Technologies Launches Capital Increase Via Private Placement